Table 2.
Patient characteristics (total patient population n = 35)
| Cohort I | Cohort II | Cohort III | Cohort IV | Cohort V | |
|---|---|---|---|---|---|
| No. of patients | 15 | 12 | 2 | 3 | 3 |
| Assessed treatment courses | 24 | 21 | 4 | 5 | 5 |
| Age (years) | |||||
| Median | 51.2 | 47.9 | 52.6 | 49.8 | 55.6 |
| Range | 25.2–69.7 | 38.3–72.2 | 47.2–57.9 | 41.9–68.3 | 49.0–64.6 |
| Sex | |||||
| Male | 4 | 0 | 0 | 2 | 2 |
| Female | 11 | 12 | 2 | 1 | 1 |
| BSA (m−2) | 1.81 | 1.82 | 1.81 | 1.82 | 1.83 |
| ECOG status | |||||
| 0 | 2 | 5 | 0 | 0 | 0 |
| 1 | 7 | 4 | 2 | 1 | 0 |
| 2 | 6 | 3 | 0 | 2 | 3 |
| Liver tumour involvement | 10 | 11 | 2 | 2 | 3 |
| Diagnosis | |||||
| Breast cancer | 7 | 9 | 2 | 2 | 2 |
| Ovarian cancer | 5 | 1 | 0 | 0 | 0 |
| Gastrointestinal cancer | 2 | 0 | 0 | 1 | 0 |
| Sarcoma | 1 | 1 | 0 | 0 | 0 |
| Gallbladder cancer | 0 | 0 | 0 | 0 | 1 |
| Endometrial cancer | 0 | 1 | 0 | 0 | 0 |
BSA, Body surface area; ECOG, Eastern Cooperative Oncology Group.